FDA
-
FDA Approves Lipfendra, First Oral PCSK9 Inhibitor for Cholesterol
The FDA has approved Lipfendra, the first daily oral PCSK9 inhibitor, offering a new treatment option for patients who require additional LDL cholesterol reduction.
-
FDA Lowers Minimum Brix Level for Pasteurized Orange Juice to Support Growers
The FDA has reduced the minimum Brix requirement for pasteurized orange juice from 10.5% to 10%, aiding growers hit by climate change and citrus greening.
-
FDA Recalls Pedigree Dog Food Over Potential Metal and Plastic Contamination
The FDA has recalled specific lots of Pedigree wet dog food due to potential contamination with metal or plastic shards after products were fraudulently diverted.
-
FDA Approves Eli Lilly’s Once-Daily Weight-Loss Pill Foundayo
The FDA has approved Eli Lilly’s orforglipron, branded as Foundayo, offering a flexible, once-daily oral option for weight management starting this April.
-
FDA Announces Recall of Over 11,000 Bottles of Blood Pressure Medication
Inventia Healthcare Limited has issued a voluntary recall for over 11,000 bottles of Chlorthalidone 25mg tablets due to failed dissolution testing.
-
Major Product Recalls Issued for Children’s Gear and Popular Food Items
A surge in safety recalls impacts major retailers, affecting children’s products due to injury risks and food items over contamination concerns.
-
FDA Recalls 11,460 Bottles of Blood Pressure Medication Over Dissolution Failure
Inventia Healthcare Limited has initiated a voluntary recall of 11,460 bottles of Chlorthalidone due to dissolution failures that may impact drug effectiveness.
-
Medical Innovation and Professional Integrity: A June 2026 Update
As the FDA nears a decision on multi-cancer blood testing, the sports world grapples with the fallout from a four-year doping suspension for former Wimbledon champion Markéta Vondroušová.
-
Over 500,000 Aldi Mac and Cheese Packages Recalled Due to Undeclared Soy
BEF Foods Inc. has issued a recall for over 500,000 units of Park St. Deli Macaroni & Cheese sold at Aldi due to undeclared soy lecithin, posing risks to consumers with allergies.
-
uniQure to Submit Huntington’s Gene Therapy for FDA Approval
Gene therapy developer uniQure announced plans to submit a Biologics License Application for its Huntington’s disease treatment, AMT-130, following positive feedback from the FDA.
-
Aldi Recalls 58,000 Cases of Mac and Cheese Over Allergen Concerns
Aldi is issuing a nationwide recall for over 58,000 cases of Park St. Deli Macaroni & Cheese due to undeclared soy, as the retailer simultaneously navigates a major UK expansion.
-
FDA Issues Urgent Recalls for Alfredo Sauce and Macaroni Products Over Safety Concerns
Federal regulators have issued major recalls for Alfredo sauce due to salmonella risks and mac and cheese products due to undeclared allergens.
-
FDA Issues Class I Recall for Alfredo Sauce Over Salmonella Risks
The Coffee Connexion Co., Inc. has initiated a Class I recall of 913 cases of Alfredo sauce distributed in 41 states following a supplier’s dry milk powder contamination.
-
Health Secretary Kennedy Faces Regulatory Friction Over Peptide Policy
Health and Human Services Secretary Robert F. Kennedy Jr. is pushing to loosen FDA restrictions on peptide injections, sparking a clash between federal policy goals and state-level medical safety boards.
-
Lucky Strike: Corporate Influence and the Sudden Reversal of FDA Vaping Policy
A $5 million donation from the parent company of Lucky Strike to a Trump-aligned PAC has ignited a firestorm of criticism following the FDA’s sudden reversal on flavored e-cigarette bans.